Skip to content

Comparison of the effect pethidine, paracetamol and their combination on the reduction of labor pain and the level of satisfaction of primiparous women

Comparison of the effect pethidine, paracetamol and their combination on the reduction of labor pain and the level of satisfaction of primiparous women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120215009014N455
Enrollment
111
Registered
2022-12-29
Start date
2023-01-21
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor pain. Maternal distress during labor and delivery

Interventions

Intervention 1: Intervention group 1: Infusion of one gr of paracetamol plus 100 ml of normal saline over 20 minutes. Intervention 2: Intervention group 2: Infusion of 25 mg of pethidine plus 100 ml o

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age of 18 to 40 years Term pregnancy A singleton with a cephalic display Cervical dilatation 4 cm Pregnant women undergoing induction of labor with oxytocin

Exclusion criteria

Exclusion criteria: Analgesic consumption in the last 24 hours Preeclampsia and eclampsia Severe obesity Intrauterine fetal death Fetal abnormalities

Design outcomes

Primary

MeasureTime frame
Labor pain intensity. Timepoint: In the first and fifth minutes after delivery. Method of measurement: Using visual analog scale (VAS).;The level of satisfaction. Timepoint: After the third stage of labor. Method of measurement: Using McKay's satisfaction questionnaire.

Secondary

MeasureTime frame
Side effects (nausea, vomiting, maternal tachycardia, respiratory depression, drowsiness, itching). Timepoint: In the first, second and third stage of labor. Method of measurement: With clinical examination and history taking.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hamideh Parsapour

Hamedan University of Medical Sciences

h.parsapour@umsha.ac.ir+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026